Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I/II Study of Paclitaxel, Estramustine Phosphate, and Vinorelbine (PaclEVin)

NCT00004105 is registered in ClinicalTrials.gov with NYU Langone Health as lead sponsor.

NCT NCT00004105
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00004105 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I/II Study of Paclitaxel, Estramustine Phosphate, and Vinorelbine (PaclEVin)
Lead sponsor
NYU Langone Health
Phase
Phase 1/2
Overall status
Completed
Start date
September 30, 1998
Completion date
Not reported
Enrollment
Not reported
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

leukemia, lymphoma, sarcoma, unspecified adult solid tumor, protocol specific